Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts
灭活全病毒COVID-19疫苗CoviVac在18-60岁和60岁以上年龄组临床试验中的安全性和免疫原性
期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v15091828
Gordeychuk, Ilya V; Kozlovskaya, Liubov I; Siniugina, Aleksandra A; Yagovkina, Nadezhda V; Kuzubov, Vladimir I; Zakharov, Konstantin A; Volok, Viktor P; Dodina, Maria S; Gmyl, Larissa V; Korotina, Natalya A; Theodorovich, Rostislav D; Ulitina, Yulia I; Vovk, Dmitry I; Alikova, Marina V; Kataeva, Anna A; Kalenskaya, Anna V; Solovjeva, Irina V; Tivanova, Elena V; Kondrasheva, Larissa Y; Ploskireva, Antonina A; Akimkin, Vasiliy G; Subbotina, Ksenia A; Ignatyev, Georgy M; Korduban, Anastasia K; Shustova, Elena Y; Bayurova, Ekaterina O; Zhitkevich, Alla S; Avdoshina, Daria V; Piniaeva, Anastasia N; Kovpak, Anastasia A; Antonova, Liliya P; Rogova, Yulia V; Shishova, Anna A; Ivin, Yury Y; Sotskova, Svetlana E; Chernov, Konstantin A; Ipatova, Elena G; Korduban, Ekaterina A; Ishmukhametov, Aydar A